11 min listen
E55: Anifrolumab for SLE (TULIP 1&2)
E55: Anifrolumab for SLE (TULIP 1&2)
ratings:
Length:
18 minutes
Released:
Jan 23, 2020
Format:
Podcast episode
Description
This week I talk about the recently published TULIP 1 and TULIP 2 trials that assessed anifrolumab for active SLE. Great to see a new drug in this disease state; interesting to think through how these trials played out. Get the papers and the pod at ebrheum.com and follow me @ebrheum if you'd like to share feedback!
Released:
Jan 23, 2020
Format:
Podcast episode
Titles in the series (87)
E17: Steroids and the Risk of Scleroderma Renal Crisis: Short but impactful paper this week on the association between steroids and scleroderma renal crisis. Find the original paper here. by The Evidence Based Rheumatology Podcast